http://orcid.org/0000-0002-7197-4676
References
- van Haasteren J, Hyde SC, Gill DR. Lessons learned from lung and liver in-vivo gene therapy: implications for the future. Expert Opin Biol Ther. 2018;18(9):959–972.
- Duncan GA, Jung J, Hanes J, Suk JS. The mucus barrier to inhaled gene therapy. Mol Ther. 2016;24(12):2043–2053.
- Hardee CL, Arévalo-Soliz LM, Hornstein BD, Zechiedrich L. Advances in non-viral DNA vectors for gene therapy. Genes (Basel). 2017;8(2):65.
- Chan JGY, Wong J, Zhou QT, Leung SSY, Chan H-K. Advances in device and formulation technologies for pulmonary drug delivery. AAPS PharmSciTech. 2014;15(4):882–897.
- Gomes dos Reis L, Svolos M, Hartwig B, Windhab N, Young PM, Traini D. Inhaled gene delivery: a formulation and delivery approach. Expert Opin Drug Deliv. 2017;14(3):319–330.
- Jaworek A, Sobczyk AT. Electrospraying route to nanotechnology: an overview. J Electrostat. 2008;66(3–4):197–219.
- Rosell-Llompart J, Fernández de la Mora J. Generation of monodisperse droplets 0.3 to 4 μm in diameter from electrified cone-jets of highly conducting and viscous liquids. J Aerosol Sci. 1994;25(6):1093–1119.
- Boehringer S, Ruzgys P, Tamo L, et al. A new electrospray method for targeted gene delivery. Sci Rep. 2018;8(1):4031.
- Zeles-Hahn MG, Lentz YK, Anchordoquy TJ, Lengsfeld CS. Effect of electrostatic spray on human pulmonary epithelial cells. J Electrostat. 2011;69(1):67–77.
- McCrea Z, Arnanthigo Y, Cryan SA, O’Dea S. A novel methodology for bio-electrospraying mesenchymal stem cells that maintains differentiation, immunomodulatory and pro-reparative functions. J Med Biol Eng. 2018;38(3):497–513.
- McClory PJ, Håkansson K. Corona discharge suppression in negative ion mode nanoelectrospray ionization via trifluoroethanol addition. Anal Chem. 2017;89(19):10188–10193.
- Griesenbach U, Vicente CC, Roberts MJ, et al. Secreted Gaussia luciferase as a sensitive reporter gene for in vivo and ex vivo studies of airway gene transfer. Biomaterials. 2011;32(10):2614–2624.
- Rogers CS, Abraham WM, Brogden KA, et al. The porcine lung as a potential model for cystic fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;295(2):L240–L263.
- Judge EP, Hughes JML, Egan JJ, Maguire M, Molloy EL, O’Dea S. Anatomy and bronchoscopy of the porcine lung: a model for translational respiratory medicine. Am J Respir Cell Mol Biol. 2014;51(3):334–343.
- Ikemoto K, Sakata I, Sakai T. Collision of millimetre droplets induces DNA and protein transfection into cells. Sci Rep. 2012;2:1–5.
- Lee YH, Wu B, Zhuang WQ, Chen DR, Tang YJ. Nanoparticles facilitate gene delivery to microorganisms via an electrospray process. J Microbiol Methods. 2011;84(2):228–233.
- Zhang D, Das DB, Rielly CD. Potential of microneedle-assisted micro-particle delivery by gene guns: a review. Drug Deliv. 2013;7544:571–587.
- Lambricht L, Lopes A, Kos S, Sersa G, Préat V, Vandermeulen G. Clinical potential of electroporation for gene therapy and DNA vaccine delivery. Expert Opin Drug Deliv. 2015;5247:295–310.
- Dean DA, Machado-Aranda D, Blair-Parks K, Yeldandi AV, Young JL. Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Ther. 2003;10(18):1608–1615.
- Golan T, Khvalevsky EZ, Hubert A, et al. RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients. Oncotarget 2015;6:24560–24570.
- Zamora MR, Budev M, Rolfe M, et al. RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med. 2011;183(4):531–538.
- Lomas-Neira JL, Chung C-S, Wesche DE, Perl M, Ayala A. In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. J Leukoc Biol. 2005;77(6):846–853.
- Davis ME, Zuckerman JE, Choi CHJ, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature. 2010;464(7291):1067–1070.